| 000 | 01869 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514161042.0 | ||
| 264 | 0 | _c20031120 | |
| 008 | 200311s 0 0 eng d | ||
| 022 | _a0146-0404 | ||
| 024 | 7 |
_a10.1167/iovs.02-1228 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSakurai, Eiji | |
| 245 | 0 | 0 |
_aScleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis. _h[electronic resource] |
| 260 |
_bInvestigative ophthalmology & visual science _cNov 2003 |
||
| 300 |
_a4845-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAbsorbable Implants |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Bacterial _xadministration & dosage |
| 650 | 0 | 4 |
_aAqueous Humor _xcytology |
| 650 | 0 | 4 | _aBiocompatible Materials |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aElectroretinography |
| 650 | 0 | 4 |
_aEye Proteins _xmetabolism |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aLactic Acid |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _ximmunology |
| 650 | 0 | 4 | _aPolyglycolic Acid |
| 650 | 0 | 4 | _aPolylactic Acid-Polyglycolic Acid Copolymer |
| 650 | 0 | 4 | _aPolymers |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aSclera |
| 650 | 0 | 4 | _aSclerostomy |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 |
_aUveitis _xchemically induced |
| 650 | 0 | 4 |
_aVitreous Body _xmetabolism |
| 700 | 1 | _aNozaki, Miho | |
| 700 | 1 | _aOkabe, Komei | |
| 700 | 1 | _aKunou, Noriyuki | |
| 700 | 1 | _aKimura, Hideya | |
| 700 | 1 | _aOgura, Yuichiro | |
| 773 | 0 |
_tInvestigative ophthalmology & visual science _gvol. 44 _gno. 11 _gp. 4845-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1167/iovs.02-1228 _zAvailable from publisher's website |
| 999 |
_c14320216 _d14320216 |
||